bioAffinity Technologies, Inc. (BIAF)
1.665
-0.04
(-2.06%)
USD |
NASDAQ |
May 20, 16:00
1.64
-0.02
(-1.50%)
After-Hours: 05:28
bioAffinity Technologies Free Cash Flow : -10.93M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Veracyte, Inc. | 155.34M |
| Insight Molecular Diagnostics, Inc. | -27.46M |
| Exagen, Inc. | -14.13M |
| GRAIL, Inc. | -292.33M |
| FONAR Corp. | 4.167M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.227M |
| Cash from Investing (Quarterly) | -0.0057M |
| Cash from Financing (Quarterly) | -0.1185M |
| Free Cash Flow Per Share (Quarterly) | -0.7193 |
| Free Cash Flow to Equity (Quarterly) | -3.455M |
| Free Cash Flow to Firm (Quarterly) | -3.218M |
| Free Cash Flow Yield | -241.8% |